PEG-ASP+Gemox Regimen and Thalidomide for NK/T Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE3
Clinical Trials Related to Gemcitabine
Related studies linked through entity extraction aliases.
A Study of Abemaciclib (LY2835219) in Combination With Another Anti-cancer Drug in Participants With Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE1
Study of IDO Inhibitor in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Chloroquine in Combination With Carboplatin/Gemcitabine in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Phase II Study Comparing LR-GEM to R-GEM-P in Second-line Treatment of Diffuse Large B-cell Lymphoma (LEGEND)
- Status
- UNKNOWN
- Phase
- PHASE2
Phase I TH-302 Plus Gemcitabine Plus Nab-Paclitaxel in Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE1
PP-Gemcitabine & External Beam Radiation-Sarcomas
- Status
- COMPLETED
- Phase
- PHASE1
Phase I Dose Escalation Study of Intravenous VCN-01 With or Without Gemcitabine and Abraxane® in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I Dose Escalation Study of Intratumoral VCN-01 Injections With Gemcitabine and Abraxane® in Patients With Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Abraxane and Gemcitabine Versus Gemcitabine Alone in Locally Advanced Unresectable Pancreatic Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
Combination Therapy With NC-6004 and Gemcitabine Versus Gemcitabine Alone in Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE3
An Open-Label, Randomized, Phase 3 Trial of Nivolumab Versus Investigator's Choice Chemotherapy as First-Line Therapy for Stage IV or Recurrent PD-L1+ Non-Small Cell Lung Cancer (CheckMate 026)
- Status
- COMPLETED
- Phase
- PHASE3
Study of Gemcitabine Maintenance Treatment in Patients With Extensive SCLC Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Dose Escalation Trial of AZD1775 and Gemcitabine (+Radiation) for Unresectable Adenocarcinoma of the Pancreas
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase II Study of Hypofractionated Radio-chemotherapy With Gemcitabine Plus Oxaliplatin for Unresectable Nonmetastatic Locally Advanced Pancreatic Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Neoadjuvant Paricalcitol to Target the Microenvironment in Resectable Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Combination of Icotinib and Gemcitabine as First-line Treatment in Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
Systemic Therapy and Chemoradiation in Advanced Localised Pancreatic Cancer - 2
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Nab-paclitaxel Combined With Gemcitabine as Adjuvant Therapy for Pancreatic Cancer After Curative Resection
- Status
- COMPLETED
- Phase
- PHASE2
A Phase Ib Study of the Safety, Tolerability and Efficacy of LY2780301 in Combination With Gemcitabine
- Status
- COMPLETED
- Phase
- PHASE1